162 related articles for article (PubMed ID: 35102778)
1. Gefitinib induced Pemphigus Vulgaris with PRIDE complex.
Kumar Chaudhary R; Bhandari R; Doshi B; Karoli SS; Spoorthi Marripalli S; Ganachari MS
J Oncol Pharm Pract; 2022 Sep; 28(6):1465-1473. PubMed ID: 35102778
[No Abstract] [Full Text] [Related]
2. A rare presentation of oral pemphigus vulgaris as multiple pustules.
Rimal J; Sumanth KN; Ongole R; George T; Chatterjee S
Kathmandu Univ Med J (KUMJ); 2007; 5(4):541-5. PubMed ID: 18604092
[TBL] [Abstract][Full Text] [Related]
3. Extensive keloid formation after pemphigus vulgaris.
Sako EY; Workwick S
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632939
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgaris.
Ojaimi S; O'Connor K; Lin MW; Schifter M; Fulcher DA
Intern Med J; 2015 Mar; 45(3):284-92. PubMed ID: 25534017
[TBL] [Abstract][Full Text] [Related]
5. Nasal, pharyngeal, and laryngeal pemphigus vulgaris successfully treated with rituximab.
Sami N
Ear Nose Throat J; 2017; 96(4-5):E35-E38. PubMed ID: 28489243
[TBL] [Abstract][Full Text] [Related]
6. Oral and cutaneous pemphigus vulgaris: an atypical clinical presentation.
Goldberg IM; Brooks JK; Ghita I; Sultan AS; MacKelfresh JB
Gen Dent; 2022; 70(6):22-26. PubMed ID: 36288071
[TBL] [Abstract][Full Text] [Related]
7. Ultra-low dose rituximab for refractory pemghigus vulgaris: a pilot study.
Russo I; Miotto S; Saponeri A; Alaibac M
Expert Opin Biol Ther; 2020 Jun; 20(6):673-678. PubMed ID: 32027810
[No Abstract] [Full Text] [Related]
8. Resolution of a case of pediatric pemphigus vulgaris treated with rituximab.
Didona D; Paolino G; Donati M; Caposeina D; Calvieri S; Didona B
Acta Dermatovenerol Croat; 2014; 22(4):288-90. PubMed ID: 25580789
[TBL] [Abstract][Full Text] [Related]
9. Crescendo response to rituximab in oral pemphigus vulgaris: a case with 7-year follow-up.
Greenblatt DT; Benton EC; Groves RW; Setterfield JF
Clin Exp Dermatol; 2016 Jul; 41(5):529-32. PubMed ID: 27061201
[TBL] [Abstract][Full Text] [Related]
10. Radiation-Associated Pemphigus Vulgaris in a Patient With Preceding Malignancy: Treatment With Rituximab as a Valuable Option.
Schauer F; Ishii N; Mockenhaupt M; Bruckner-Tuderman L; Hashimoto T; Kiritsi D
Front Immunol; 2019; 10():3116. PubMed ID: 32038636
[TBL] [Abstract][Full Text] [Related]
11. Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.
Agarwal A; Hall RP; Bañez LL; Cardones AR
PLoS One; 2018; 13(9):e0198074. PubMed ID: 30252855
[TBL] [Abstract][Full Text] [Related]
12. Intermediate doses of rituximab used as adjuvant therapy in refractory pemphigus.
Londhe PJ; Kalyanpad Y; Khopkar US
Indian J Dermatol Venereol Leprol; 2014; 80(4):300-5. PubMed ID: 25035353
[TBL] [Abstract][Full Text] [Related]
13. [Unexpected positive outcome following rituximab treatment in a patient with pemphigus vegetans resistant to conventional therapies: a case report].
Barbach Y; Baybay H; Mrabat S; Chaouche M; Elloudi S; Mernissi FZ
Pan Afr Med J; 2019; 32():101. PubMed ID: 31223391
[TBL] [Abstract][Full Text] [Related]
14. Pemphigus vegetans with paronychia-like changes resistant to rituximab therapy.
Ayoubi N; Rudnick E; Motaparthi K
Dermatol Ther; 2020 Jul; 33(4):e13515. PubMed ID: 32367637
[TBL] [Abstract][Full Text] [Related]
15. Clinical resolution of pemphigus vulgaris on rituximab.
Cusick E; Silverstein D
Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469734
[TBL] [Abstract][Full Text] [Related]
16. Pemphigus vulgaris with psoriasis vulgaris successfully treated with methotrexate and low-dose methylprednisolone.
Zheng J; Liu N; Wang Y; Chen F; Ding Y
Dermatol Ther; 2020 Jan; 33(1):e13165. PubMed ID: 31705774
[TBL] [Abstract][Full Text] [Related]
17. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris.
Hayag MV; Cohen JA; Kerdel FA
J Am Acad Dermatol; 2000 Dec; 43(6):1065-9. PubMed ID: 11100024
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.
Ahmed AR; Spigelman Z; Cavacini LA; Posner MR
N Engl J Med; 2006 Oct; 355(17):1772-9. PubMed ID: 17065638
[TBL] [Abstract][Full Text] [Related]
19. Severe multi-resistant pemphigus vulgaris: prolonged remission with a single cycle of rituximab.
Corral IS; Freitas TH; Aquino RT; Koller DA; Magliari ME; Muller H
An Bras Dermatol; 2013; 88(4):639-42. PubMed ID: 24068143
[TBL] [Abstract][Full Text] [Related]
20. [Juvenile pemphigus vulgaris].
Janisson-Dargaud D; Reguiaï Z; Perceau G; Eschard C; Bernard P
Ann Dermatol Venereol; 2008 Dec; 135(12):843-7. PubMed ID: 19084695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
